Riamilovir New

Data Sheet For research use only. Not for human use.

Cat. No. ：BCP41717CAS No. ：123606-06-4Purity：98%

Get Quotation Now

Tel: 0086-13026320035 or orders@biochempartner.com

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS No.	123606-06-4	Cat. No.	BCP41717
Name	Riamilovir
Synonyms	Triazavirin; TZV;
SMILES	CSC1=NC2=NN=C(C(=O)N2N1)[N+](=O)[O-]
Chemical Name
Formula	C5H4N6O3S	M. Wt	228.19
Purity	98%	Storage	Store at 4-8°C
Description	Riamilovir, also known as Triazavirin, is an antiviral drug candidate. Tiazavirin is a broad-spectrum antiviral drug developed in Russia. It has a novel triazolotriazine core, which represents a new structural class of non-nucleoside antiviral drugs. It was originally developed as a potential treatment for pandemic influenza strains such as H5N1, and most of the testing that has been done has focused on its anti-influenza activity. However triazavirin has also been found to have antiviral activity against a number of other viruses including Tick-borne encephalitis virus, and Forest-Spring Encephalitis virus, and is also being investigated for potential application against Lassa fever and Ebola virus disease. In February 2020, testing of triazavirin was started against SARS-CoV-2.